Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Selection for hepatic resection of colorectal liver metastases: expert consensus statement.

Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN; Americas Hepato-Pancreato-Biliary Association.; Society of Surgical Oncology.; Society for Surgery of the Alimentary Tract..

HPB (Oxford). 2013 Feb;15(2):91-103. doi: 10.1111/j.1477-2574.2012.00557.x.

2.

[Diagnosis and treatment of colorectal liver metastases - workflow].

Grundmann RT, Hermanek P, Merkel S, Germer CT, Grundmann RT, Hauss J, Henne-Bruns D, Herfarth K, Hermanek P, Hopt UT, Junginger T, Klar E, Klempnauer J, Knapp WH, Kraus M, Lang H, Link KH, Löhe F, Merkel S, Oldhafer KJ, Raab HR, Rau HG, Reinacher-Schick A, Ricke J, Roder J, Schäfer AO, Schlitt HJ, Schön MR, Stippel D, Tannapfel A, Tatsch K, Vogl TJ; Arbeitsgruppe Workflow Diagnostik und Therapie von Lebermetastasen kolorektaler Karzinome..

Zentralbl Chir. 2008 Jun;133(3):267-84. doi: 10.1055/s-2008-1076796. Review. German.

PMID:
18563694
3.

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F.

J Nucl Med. 2013 Dec;54(12):2062-9. doi: 10.2967/jnumed.113.119909. Epub 2013 Oct 17.

4.

Selection for hepatic resection: expert consensus conference.

Rees M, Elias D, Coimbra FJ, Orloff SL; Americas Hepato-Pancreato-Biliary Association.; Society of Surgical Oncology.; Society for Surgery of the Alimentary Tract..

HPB (Oxford). 2013 Feb;15(2):104-5. doi: 10.1111/j.1477-2574.2012.00568.x. Epub 2012 Oct 17. No abstract available.

5.

Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.

Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, Curley SA, Abdalla EK, Kaur H, Charnsangavej C, Loyer EM.

JAMA. 2009 Dec 2;302(21):2338-44. doi: 10.1001/jama.2009.1755.

6.

Detection of liver metastasis: is diffusion-weighted imaging needed in Gd-EOB-DTPA-enhanced MR imaging for evaluation of colorectal liver metastases?

Tajima T, Akahane M, Takao H, Akai H, Kiryu S, Imamura H, Watanabe Y, Kokudo N, Ohtomo K.

Jpn J Radiol. 2012 Oct;30(8):648-58. doi: 10.1007/s11604-012-0105-4. Epub 2012 Jul 18.

PMID:
22836904
7.

The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus.

Adam R, De Gramont A, Figueras J, Guthrie A, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Tabernero J, Teh C, Van Cutsem E; Jean-Nicolas Vauthey of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group..

Oncologist. 2012;17(10):1225-39. doi: 10.1634/theoncologist.2012-0121. Epub 2012 Sep 7.

8.

Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.

Bipat S, van Leeuwen MS, Ijzermans JN, Bossuyt PM, Greve JW, Stoker J.

Neth J Med. 2006 May;64(5):147-51.

9.

[Use of PET-CT in pre-surgical staging of colorectal cancer hepatic metastases].

Ramos E, Martínez L, Gámez C, Torras J, Valls C, Rafecas A, Lladó L, Jorba R, Ruiz S, Serrano T, Fabregat J.

Cir Esp. 2008 Aug;84(2):71-7. Spanish.

10.

Bevacizumab treatment before resection of colorectal liver metastases: safety, recovery of liver function, pathologic assessment.

Dede K, Mersich T, Besznyák I, Zaránd A, Salamon F, Baranyai ZS, Landherr L, Jakab F, Bursics A.

Pathol Oncol Res. 2013 Jul;19(3):501-8. doi: 10.1007/s12253-013-9608-2. Epub 2013 Feb 19.

PMID:
23420304
11.

Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.

Anzidei M, Napoli A, Zaccagna F, Cartocci G, Saba L, Menichini G, Cavallo Marincola B, Marotta E, Di Mare L, Catalano C, Passariello R.

J Comput Assist Tomogr. 2011 Nov-Dec;35(6):690-6. doi: 10.1097/RCT.0b013e318230d905. Erratum in: J Comput Assist Tomogr. 2012 Sep;36(5):627. Marincola, Beatrice Cavallo [corrected to Cavallo Marincola, Beatrice].

PMID:
22082538
12.

Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.

Abbadi RA, Sadat U, Jah A, Praseedom RK, Jamieson NV, Cheow HK, Whitley S, Ford HE, Wilson CB, Harper SJ, Huguet EL.

J Surg Oncol. 2014 Sep;110(3):313-9. doi: 10.1002/jso.23623. Epub 2014 Apr 16.

PMID:
24737685
13.
14.

Predictive value of optimal morphologic response to first-line chemotherapy in patients with colorectal liver metastases.

Yoshita H, Hosokawa A, Ueda A, Ando T, Kajiura S, Kato H, Kawabe H, Tomizawa G, Horikawa N, Yabuhita K, Note M, Sugiyama T.

Digestion. 2014;89(1):43-8. doi: 10.1159/000356218. Epub 2014 Jan 20.

PMID:
24458112
15.

Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA.

Ann Surg Oncol. 2006 Oct;13(10):1261-8. Epub 2006 Sep 1. No abstract available.

PMID:
16947009
16.

Volumetric analysis of remnant liver regeneration after major hepatectomy in bevacizumab-treated patients: a case-matched study in 82 patients.

Millet G, Truant S, Leteurtre E, Hebbar M, Zerbib P, Huet G, Boleslawski E, Pruvot FR.

Ann Surg. 2012 Nov;256(5):755-61; discussion 761-2. doi: 10.1097/SLA.0b013e31827381ca.

PMID:
23095619
17.

Treatment of liver metastases, an update on the possibilities and results.

Ruers T, Bleichrodt RP.

Eur J Cancer. 2002 May;38(7):1023-33. Review.

PMID:
11978527
18.

Selection of patients for resection of hepatic colorectal metastases: expert consensus statement by Charnsangavej et al.

Chapman WC, Hoff PM, Strasberg SM.

Ann Surg Oncol. 2006 Oct;13(10):1269-70. Epub 2006 Sep 3. No abstract available.

PMID:
16952024
19.

Expanding criteria for resectability of colorectal liver metastases.

Pawlik TM, Schulick RD, Choti MA.

Oncologist. 2008 Jan;13(1):51-64. doi: 10.1634/theoncologist.2007-0142. Review.

20.

Intrahepatic cholangiocarcinoma: expert consensus statement.

Weber SM, Ribero D, O'Reilly EM, Kokudo N, Miyazaki M, Pawlik TM.

HPB (Oxford). 2015 Aug;17(8):669-80. doi: 10.1111/hpb.12441.

Supplemental Content

Support Center